GLOBAL ALOPECIA (HAIR LOSS) TREATMENT MARKET FORECAST 2019-2027

1
ALOPECIA (HAIR LOSS) TREATMENT MARKET
FORECAST 2019-2027
2
(No Transcript)
3

• The global alopecia treatment market is expected
  to proliferate at 5.51 CAGR during the
  forecasting years of 2019-2027.
• The alopecia (hair loss) treatment market in
  North America is expected to hold the largest
  share by 2027 and is expected to grow at a CAGR
  of xx during the forecasting years.

4

• Growing disposable income coupled with the rising
  penetration of celebrity culture among the mass
  and the increased emphasis on visual appearance
  is contributing to the alopecia treatment market
  growth.
• Increasing cases of chronic diseases such as
  Polycystic Ovary Syndrome (PCOS), Rheumatoid
  Arthritis and cancer causes a higher rate of
  occurrence of alopecia which is further profiting
  the said market.
• The high economic development in the developing
  countries and the initiatives of organizations,
  such as National Alopecia Areata Foundation,
  American Hair Loss Association, etc. across
  several corners of the world are helping to
  spread awareness about alopecia and the available
  treatments are resulting in growth in healthcare
  expenditure specifically for the market.

5
(No Transcript)
6
The global alopecia treatment market is expected
to proliferate at 5.51 CAGR during the
forecasting years of 2019-2027.
7
The alopecia treatment market of North America is
expected to proliferate at a growth rate of 4.80
CAGR during the forecasting years of 2019-2027.
8
The European alopecia treatment market is
expected to grow at a CAGR of 4.52 during the
forecasting years 2019-2027.
9
The Asia Pacific alopecia treatment market is
expected to grow at a CAGR of 7.38 during the
forecasting years of 2019-2027.
10
Concert Pharmaceuticals Inc., Histogen Inc., Dr
Reddys Laboratories Ltd., Merck Co., Inc.,
Alès Groupe, Alpecin, Sun Pharmaceutical
Industries Ltd., Vitabiotics Ltd., Aclaris
Therapeutics Inc., Johnson and Johnson,
GlaxoSmithKline, Daiichi Sankyo, Inc.,
Lifes2good, Cipla and HCell Inc. are some of the
companies operating in the global market.
11
(No Transcript)
12
(No Transcript)
13
(No Transcript)